Author:
Felip E.,Altorki N.,Zhou C.,Vallières E.,Martínez-Martí A.,Rittmeyer A.,Chella A.,Reck M.,Goloborodko O.,Huang M.,Belleli R.,McNally V.,Srivastava M.K.,Bennett E.,Gitlitz B.J.,Wakelee H.A.
Reference23 articles.
1. Current status of immune checkpoint inhibition in early-stage NSCLC;Vansteenkiste;Ann Oncol,2019
2. Neoadjuvant and adjuvant immunotherapy in early-stage non-small-cell lung cancer, past, present, and future;Szeto;J Clin Med,2021
3. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer;Arriagada;N Engl J Med,2004
4. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group;Pignon;J Clin Oncol,2008
5. Adjuvant chemotherapy for resected early-stage non-small cell lung cancer;Burdett;Cochrane Database Syst Rev,2015
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献